EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach

Sudais Rahman iD, Chien-Chun Chiou, Mashal M Almutairi iD, Amar Ajmal, Sidra Batool, Bushra Javed, Tetsuya Tanaka iD, Chien-Chin Chen iD, Abdulaziz Alouffi iD, Abid Ali iD

Viruses · 03.09.2024 · 16 (9) · 1408

DOI: 10.3390/v16091408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 03.09.2024. Verfasst von Sudais Rahman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Abdul Wali Khan University, Mardan 23200, Khyber Pakhtunkhwa, Pakistan. Hauptthemen laut MEDLINE: Epitopes, T-Lymphocyte, Epitopes, B-Lymphocyte, Computational Biology, Viral Vaccines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The researchers supporting project number (RSP2024R494), King Saud University, Riyadh, Saudi Arabia., King Saud University, Riyadh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel tick-borne orthonairovirus called the Yezo virus (YEZV), primarily transmitted by the Ixodes persulcatus tick, has been recently discovered and poses significant threats to human health. The YEZV is considered endemic in Japan and China. Clinical symptoms associated with this virus include thrombocytopenia, fatigue, headache, leukopenia, fever, depression, and neurological complications ranging from mild febrile illness to severe outcomes like meningitis and encephalitis. At present, there is no treatment or vaccine readily accessible for this pathogenic virus. Therefore, this research employed an immunoinformatics approach to pinpoint potential vaccine targets within the YEZV through an extensive examination of its structural proteins. Three structural proteins were chosen using specific criteria to pinpoint T-cell and B-cell epitopes, which were subsequently validated through interferon-gamma induction. Six overlapping epitopes for cytotoxic T-lymphocytes (CTL), helper T-lymphocytes (HTL), and linear B-lymphocytes (LBL) were selected to construct a multi-epitope vaccine, achieving a 92.29% coverage of the global population. These epitopes were then fused with the 50S ribosomal protein L7/L12 adjuvant to improve protection against international strains. The three-dimensional structure of the designed vaccine construct underwent an extensive evaluation through structural analysis. Following molecular docking studies, the YEZV vaccine construct emerged as a candidate for further investigation, showing the lowest binding energy (−78.7 kcal/mol) along with favorable physiochemical and immunological properties. Immune simulation and molecular dynamics studies demonstrated its stability and potential to induce a strong immune response within the host cells. This comprehensive analysis indicates that the designed vaccine construct could offer protection against the YEZV. It is crucial to conduct additional in vitro and in vivo experiments to verify its safety and effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epitopes, T-LymphocyteEpitopes, B-LymphocyteComputational BiologyViral VaccinesAnimalsHumansViral Structural ProteinsMiceT-Lymphocytes, CytotoxicMolecular Docking SimulationImmunoinformatics

Stichwörter der Autor:innen

Yezo virusimmunoinformaticsmolecular dockingmolecular dynamic simulationmulti-epitope vaccine

Substanzen

Epitopes, T-LymphocyteEpitopes, B-LymphocyteViral VaccinesViral Structural Proteins

Autor:innen und Institutionen

  • Department of Zoology, Abdul Wali Khan University, Mardan 23200, Khyber Pakhtunkhwa, Pakistan.
  • Department of Dermatology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 600, Taiwan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Biochemistry, Abdul Wali Khan University, Mardan 23200, Khyber Pakhtunkhwa, Pakistan.
  • Laboratory of Animal Microbiology, Graduate School of Agricultural Science/Faculty of Agriculture, Tohoku University, 468-1 Aramaki Aza Aoba, Aoba-ku, Sendai 980-8572, Japan.
  • Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 600, Taiwan.

ORCID-Profile: Sudais Rahman, Mashal M Almutairi, Tetsuya Tanaka, Chien-Chin Chen, Abdulaziz Alouffi, Abid Ali

Förderung

  • The researchers supporting project number (RSP2024R494), King Saud University, Riyadh, Saudi Arabia.
  • King Saud University, Riyadh

Zitieren

APA

Rahman, S., Chiou, C. C., Almutairi, M. M., Ajmal, A., Batool, S., Javed, B., Tanaka, T., Chen, C. C., Alouffi, A., & Ali, A. (2024). Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach. Viruses, 16(9), 1408. https://doi.org/10.3390/v16091408

Vancouver

Rahman S, Chiou CC, Almutairi MM, Ajmal A, Batool S, Javed B, et al. Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach. Viruses. 2024;16(9):1408. doi:10.3390/v16091408

BibTeX
@article{Rahman2024,
  author = {Rahman, Sudais and Chiou, Chien-Chun and Almutairi, Mashal M and Ajmal, Amar and Batool, Sidra and Javed, Bushra and Tanaka, Tetsuya and Chen, Chien-Chin and Alouffi, Abdulaziz and Ali, Abid},
  title = {Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1408},
  doi = {10.3390/v16091408}
}
Kostenlos starten →